Bpifrance

ChapsVision specializes in providing a data analysis platform that addresses complex business challenges for sectors with significant data footprints, such as Retail, Finance, and Public Services. The company offers a comprehensive suite of business solutions that are fully integrated around a unified Customer and Product repository. This modern analytical infrastructure equips clients with intelligence, investigation, and analysis tools that consolidate data from various sources into a single workspace. By doing so, ChapsVision supports its customers in effectively navigating and optimizing their digital transformation processes.

UnitySC is recognized worldwide as a key player in inspection and metrology, combining advanced technologies in automated optical inspection and 3D imaging with high depth of focus line scanning, temporal-mode interferometry, spectrometry, and phase shift analysis. This enables customers to deliver higher yields and achieve faster time to market. We provide standard and customized solutions adapted to specific industrial needs and constraints, enabling a new era in process control.

SightCall is a provider of a live video platform designed to enhance enterprise operations through visual support. Founded in 2007 and based in Issy-les-Moulineaux, France, with an additional office in San Francisco, the company offers a suite of mobile and web applications that enable businesses to see what their customers see, facilitating remote guidance. Its platform integrates Augmented Reality and Artificial Intelligence to enrich the user experience and improve problem-solving efficiency across various industries, including insurance, telecommunications, transportation, telehealth, and manufacturing. SightCall's services allow enterprises to streamline processes, enhance customer satisfaction, and leverage real-time communication through a secure, scalable infrastructure.

Pixyl SAS develops automatic neuroimaging solutions. The company provides quantitative neuroimaging biomarker extraction for improved insight and decision-making in clinical studies and routine clinical practice. Its automatic neuroimaging segmentation plugins are designed for integration into the workflows of imaging CROs, neuroradiologists, and neurologists; and algorithms are available for multiple sclerosis, chronic stroke, and traumatic brain injury applications. The company was founded in 2015 and is based in Montbonnot-Saint-Martin, France.

Newsbridge is a company based in Boulogne-Billancourt, France, that specializes in contribution and image processing solutions. Founded in 2016, it focuses on producing content for television channels, production houses, and agencies. Newsbridge offers AI-based video indexing tools designed to assist publishers and broadcasters in streamlining their production processes and enhancing the value of their content through improved indexing.

Surgivisio SAS is a French company, established in 2009 and based in La Tronche, that specializes in developing and manufacturing healthcare technologies. The company's focus lies in 2D and 3D imaging, real-time surgical navigation, and computer-assisted minimally-invasive surgery, with a particular emphasis on applications in orthopedics and traumatology. The Surgivisio device is classified as a CE-marked IIb-class medical device, indicating its compliance with regulatory standards for safety and effectiveness. Conformity assessment for the device has been conducted by G-MED, ensuring adherence to industry regulations.

We develop pioneering technology to empower analysts to take smart actions for a safer world. Our artificial intelligence solutions are based on an automated analysis of geospatial intelligence (GEOINT) workflows. Powering state-of-the-art Machine Learning and Computer Vision, we aggregate information from multi-intelligence sources (Multi-INT), such as imagery (IMINT), electromagnetic (ELINT), or open source (OSINT), to provide our Defence and Intelligence customers with strategic knowledge regarding mission critical areas of interest ensuring a more insightful operating picture.

SparingVision SAS is a biotechnology company based in Paris, France, focused on discovering and developing gene therapy-based treatments for blinding inherited retinal diseases. Founded in 2016, the company is working on SPVN06, a gene-independent therapy aimed at treating retinitis pigmentosa, the most common form of inherited retinal degeneration. This condition affects nearly 2 million people globally and currently lacks comprehensive treatment options for its various genetic forms. SparingVision’s efforts aim to provide innovative solutions for patients suffering from these debilitating diseases, enabling healthcare professionals to offer improved care for those at risk of blindness.

Pixium Vision SA is a Paris-based company focused on developing implantable medical devices to address blindness caused by the degeneration of retinal photoreceptor cells. The company is known for its bionic vision system, the PRIMA System, which aims to restore vision and enhance the quality of life for individuals suffering from vision loss. Additionally, Pixium Vision is advancing its retinal implant technologies through devices such as the IRIS1, currently in clinical trials, and the upcoming IRIS2, which promises improved visual acuity. The company is also working on the IRIS3 sub-retinal implant, leveraging cutting-edge advancements in neural processing and micro-electronics. Founded in 2011 as a spin-out from the Vision Institute and Université Pierre et Marie Curie, Pixium collaborates with leading institutions, including Stanford University and Moorfields Eye Hospital, to further its research and development efforts. The company is supported by prominent European venture capital firms.

Laclarée Vision, founded in 2016 and based in Lyon, France, specializes in developing adaptive eyeglasses designed to correct presbyopia. The company employs patented fluid technology to create variable-focus lenses that automatically adjust to the viewer's distance, providing clear vision at all ranges. This innovation targets individuals aged 45 and older who are dissatisfied with traditional solutions, such as progressive lenses or multiple pairs of glasses. By integrating advanced adaptive lens technology, Laclarée aims to enhance the visual experience for those with additional refractive errors like astigmatism, myopia, or hyperopia.

Foodvisor is a nutrition application that assists users in making healthier dietary choices by utilizing smartphone cameras to identify food items and estimate serving sizes. The app provides detailed nutritional information rapidly, allowing users to access essential data about their meals. This functionality goes beyond merely counting calories; it aims to promote healthier eating habits and support users in achieving a balanced diet. By combining technology with nutritional guidance, Foodvisor empowers individuals to improve their dietary habits effectively.

Isorg SA, founded in 2010 and based in Grenoble, France, specializes in the development and manufacturing of organic and printed electronic devices, particularly in the fields of photonics and image sensors. The company is noted for its innovative high-performance opto-electronic sensors, which can be integrated into various products, transforming surfaces made of plastic or glass into smart interfaces. Isorg offers a comprehensive range of services, from proof-of-concept to mass production, catering to diverse applications across consumer electronics, home appliances, smart buildings, industrial sectors, healthcare, and safety. Additionally, the company provides support for product development and integration. Its technology includes large-area image sensors and photodetectors, contributing to sectors such as medical imaging, non-destructive testing, and data security.

Gleamer SAS is a Paris-based company founded in 2017 that specializes in artificial intelligence software designed for medical imaging diagnosis. Its flagship product, BoneView, utilizes AI technology to automatically detect traumatic injuries and bone abnormalities in radiographic images. This software assists radiologists by providing preliminary data for diagnosis, highlighting potential lesions, and improving overall productivity in clinical settings. By integrating this technology into hospitals and clinics, Gleamer aims to enhance the accuracy and efficiency of radiological assessments, enabling radiologists to prioritize patients effectively and reduce the risk of overlooking critical conditions.

Surgivisio SAS is a French company, established in 2009 and based in La Tronche, that specializes in developing and manufacturing healthcare technologies. The company's focus lies in 2D and 3D imaging, real-time surgical navigation, and computer-assisted minimally-invasive surgery, with a particular emphasis on applications in orthopedics and traumatology. The Surgivisio device is classified as a CE-marked IIb-class medical device, indicating its compliance with regulatory standards for safety and effectiveness. Conformity assessment for the device has been conducted by G-MED, ensuring adherence to industry regulations.

Qopius Technology, founded in 2015 and based in Paris, France, specializes in developing an application programming interface that allows retailers, brands, and distributors to create artificial intelligence modules for image recognition. The company's innovative solution integrates connected cameras and AI to assess shelf composition in hypermarkets and convenience stores. Qopius aims to enhance retail operations by digitizing shelves, enabling retailers to measure shelf performance, boost productivity, and minimize out-of-stock situations. Its Retail Pulse platform assists major players in the fast-moving consumer goods sector by monitoring product behavior on shelves and facilitating real-time corrective actions. With a vision of a fully connected store, Qopius is working towards a seamless shopping experience that eliminates waiting in line and ensures optimal product placement. As of February 2020, Qopius operates as a subsidiary of Trax Technology Solutions Pte Ltd.

We develop pioneering technology to empower analysts to take smart actions for a safer world. Our artificial intelligence solutions are based on an automated analysis of geospatial intelligence (GEOINT) workflows. Powering state-of-the-art Machine Learning and Computer Vision, we aggregate information from multi-intelligence sources (Multi-INT), such as imagery (IMINT), electromagnetic (ELINT), or open source (OSINT), to provide our Defence and Intelligence customers with strategic knowledge regarding mission critical areas of interest ensuring a more insightful operating picture.

Deepomatic is a Paris-based company founded in 2014 that specializes in AI-driven software solutions for computer vision. It offers tools such as Deepomatic Studio, which enables users to design custom video recognition systems, and Deepomatic Run, which facilitates the operation of image recognition applications in production. The platform allows businesses to address image-related challenges by uploading images, training models through manual annotation and active learning, and deploying APIs. Deepomatic serves a diverse clientele, including Global 500 companies across various sectors such as automotive, healthcare, construction, oil and gas, pharmaceuticals, public transport, and retail. The company also has an office in New York, further expanding its reach in the technology landscape.

Horama SAS is a biotechnology company based in Paris, France, established in 2014. It specializes in developing gene therapy products aimed at treating rare ophthalmic diseases, particularly targeting inherited retinal dystrophies and retinopathies. By utilizing recombinant adeno-associated viral vectors, Horama's therapies aim to deliver a functional copy of mutated genes to affected retinal cells. This approach seeks to restore normal cell function, prevent further deterioration of vision, and ultimately improve or restore visual capabilities for patients. The company is positioning itself as a significant player in the ophthalmic gene therapy sector, with the goal of enhancing patient autonomy while also contributing to reduced healthcare costs.

Vi Technology specializes in automated optical inspection systems and software solutions tailored for the electronics industry, particularly focusing on the PCB assembly process and solder paste inspection. The company provides advanced systems that meet the surface mount technology (SMT) inspection requirements, ensuring both high performance and user-friendliness. With over 3,500 installed systems worldwide, Vi Technology serves a diverse range of sectors, including automotive, aeronautics, and space industries. Their offerings include integrated base-band test equipment designed for audio, video, and multimedia tests, as well as tools that help improve yield by translating inspection data into actionable process information. Additionally, Vi Technology has a robust support organization operating in 40 countries, backed by a team of experienced application and support specialists, along with a network of qualified partners.

Isorg SA, founded in 2010 and based in Grenoble, France, specializes in the development and manufacturing of organic and printed electronic devices, particularly in the fields of photonics and image sensors. The company is noted for its innovative high-performance opto-electronic sensors, which can be integrated into various products, transforming surfaces made of plastic or glass into smart interfaces. Isorg offers a comprehensive range of services, from proof-of-concept to mass production, catering to diverse applications across consumer electronics, home appliances, smart buildings, industrial sectors, healthcare, and safety. Additionally, the company provides support for product development and integration. Its technology includes large-area image sensors and photodetectors, contributing to sectors such as medical imaging, non-destructive testing, and data security.

Pixium Vision SA is a Paris-based company focused on developing implantable medical devices to address blindness caused by the degeneration of retinal photoreceptor cells. The company is known for its bionic vision system, the PRIMA System, which aims to restore vision and enhance the quality of life for individuals suffering from vision loss. Additionally, Pixium Vision is advancing its retinal implant technologies through devices such as the IRIS1, currently in clinical trials, and the upcoming IRIS2, which promises improved visual acuity. The company is also working on the IRIS3 sub-retinal implant, leveraging cutting-edge advancements in neural processing and micro-electronics. Founded in 2011 as a spin-out from the Vision Institute and Université Pierre et Marie Curie, Pixium collaborates with leading institutions, including Stanford University and Moorfields Eye Hospital, to further its research and development efforts. The company is supported by prominent European venture capital firms.